2013
DOI: 10.1016/j.jalz.2013.02.008
|View full text |Cite
|
Sign up to set email alerts
|

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease

Abstract: The results indicate that APOE ε4 has a moderate effect on WM integrity in HCs, but no effect on WM integrity in manifest AD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 17 publications
1
23
1
Order By: Relevance
“…27 All healthy control subjects scored 0 in the CDR rating. 28 In the AD/MCI group, four subjects carried at least one ApoE4 allele, in the control group one subject carried one ApoE4 allele (not significantly different between groups, Fisher's exact test, P = .32). Furthermore we examined the apolipoprotein E (APOE) genotype of all subjects.…”
Section: Subjects and Methods Subjectsmentioning
confidence: 90%
“…27 All healthy control subjects scored 0 in the CDR rating. 28 In the AD/MCI group, four subjects carried at least one ApoE4 allele, in the control group one subject carried one ApoE4 allele (not significantly different between groups, Fisher's exact test, P = .32). Furthermore we examined the apolipoprotein E (APOE) genotype of all subjects.…”
Section: Subjects and Methods Subjectsmentioning
confidence: 90%
“…DTI studies suggest that it may be an early indicator for Alzheimer's disease related neurodegeneration in elderly subjects (15,16). In addition to aging, the ApoE4 genotype is an important modulator of brain structure in cognitively unimpaired subjects (17,18) and adds to the risk for sporadic Alzheimer's disease (19).…”
mentioning
confidence: 99%
“…As of March 2016, it encompasses data from 13 scanners. EDSD data has already been used in numerous studies, assessing research questions such as the multicentric variability of DTI parameters derived from heterogeneous acquisition schemes, the diagnostic and prognostic potential of specific DTI parameters, as well as the utility of post-acquisition processing approaches that may improve these parameters by reducing multicentric variability (Brueggen et al, 2015;Dyrba et al, 2015;Dyrba et al, 2014;Dyrba et al, 2012;Dyrba et al, 2013;Fischer et al, 2012;Kljajevic et al, 2014;Teipel et al, 2014a;Teipel et al, 2014b;Teipel et al, 2011;Teipel et al, 2012). In the future, the data set will be continuously expanded through ongoing support from the existing partner centers as well as the steady inclusion of new centers.…”
Section: Discussionmentioning
confidence: 99%